Copyright © 2004 by the European Society of Cardiology.
Clinical research
Use of implantable loop recorders in the diagnosis and management of syncope
Department of Cardiology, Eastbourne District General Hospital, King's Drive, Eastbourne, East Sussex BN21 2UD, UK
Department of Primary Care and General Practice, University of Birmingham, UK
* Corresponding author. Tel.: +44-1323-417400; fax: +44-1323-414993
E-mail address: djfarwell{at}bigfoot.com
Received 12 September 2003; revised 27 January 2004; accepted 4 March 2004
Abstract
Background Syncope is a common, disabling symptom. The most useful data for diagnosing and managing syncope is the recording of physical parameters such as the ECG and blood pressure during a spontaneous event. Implantable loop recorders (ILR) provide an opportunity to record ECG data from a spontaneous event. The purpose of the Eastbourne Syncope Assessment Study (EaSyAS) was to investigate the impact of ILRs on an unselected population of syncopal patients presenting acutely to our institution.
Methods All patients presenting acutely with recurrent, unexplained syncope over a 16-month period, were randomised after a basic clinical workup to receive the Reveal Plus ILR or conventional investigation. All patients were followed up for at least 6 months (mean 276±134 days) following randomisation. The primary outcome measure was time to ECG diagnosis.
Results Four hundred twenty-one patients presented, 201 were eligible, median age 74 years (interquartile range 61–81 years), 54% female, with a median of three previous syncopes (IQ range 2–6). Thirty-three percent of ILR patients and 4% of conventional patients had an ECG diagnosis (hazard ratio 8.93, 95% CI 3.17–25.2 
). Introduction of ECG-directed therapy was quicker for ILR patients (hazard ratio 7.9, 95% CI 2.8–22.3, 
). ILR patients had fewer post-randomisation investigations and fewer hospital days, resulting in a saving of costs, £406 versus £1210 (mean difference £809, 95% CI £123–£2730). There was no difference in the number of subsequent syncopal episodes, mortality, or quality of life.
Conclusions LR significantly increased the rate of diagnosis in an unselected Western population with recurrent syncope. There was a significant decrease in the rates of hospitalisation and investigation in patients receiving an ILR.
Key Words: Syncope • ILR • Cost effectiveness • Arrhythmia
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. J. Turley, M. M. Tynan, and C. J. Plummer Time to manual activation of implantable loop recorders--implications for programming recording period: a 10-year single-centre experience Europace, October 1, 2009; 11(10): 1359 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Benditt and J. T. Nguyen Syncope: therapeutic approaches. J. Am. Coll. Cardiol., May 12, 2009; 53(19): 1741 - 1751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Maggi, C. Menozzi, M. Brignole, C. Podoleanu, M. Iori, R. Sutton, A. Moya, F. Giada, S. Orazi, and N. Grovale Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope Europace, August 1, 2007; 9(8): 563 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sud, G. J. Klein, A. C. Skanes, L. J. Gula, R. Yee, and A. D. Krahn Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope Europace, May 1, 2007; 9(5): 312 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brignole, R. Sutton, C. Menozzi, R. Garcia-Civera, A. Moya, W. Wieling, D. Andresen, D. G. Benditt, N. Grovale, T. De Santo, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope Eur. Heart J., September 2, 2006; 27(18): 2232 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brignole, R. Sutton, C. Menozzi, R. Garcia-Civera, A. Moya, W. Wieling, D. Andresen, D. G. Benditt, P. Vardas, and for the International Study on Syncope of Uncertai Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope Eur. Heart J., May 1, 2006; 27(9): 1085 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farwell, N. Freemantle, and N. Sulke The clinical impact of implantable loop recorders in patients with syncope Eur. Heart J., February 1, 2006; 27(3): 351 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Other articles noted Evid. Based Med., November 1, 2004; 9(6): 191 - 192. [Full Text] [PDF]
|
|